These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6111176)

  • 1. Effects of short-term and prolonged infusions of somatostatin on endocrine pancreas, body weight and food intake in rats.
    Lins PE; Petersson B; Efendić S
    Acta Physiol Scand; 1980 Nov; 110(3):267-75. PubMed ID: 6111176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin-28 is longer acting and more selective than somatostatin-14 on pituitary and pancreatic hormone release.
    Tannenbaum GS; Ling N; Brazeau P
    Endocrinology; 1982 Jul; 111(1):101-7. PubMed ID: 6123428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-exposure to glucagon impairs glucose recovery after insulin-induced hypoglycemia in man.
    Clausen N; Adamson U; Lins PE
    Horm Metab Res; 1987 Aug; 19(8):375-8. PubMed ID: 2889657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS; Ho LT
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Route of administration as a factor in the selectivity of hormone suppression of a somatostatin analog in rats.
    Lien EL; Garsky VM
    Horm Metab Res; 1981 Dec; 13(12):675-8. PubMed ID: 6119282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis.
    Chideckel EW; Palmer J; Koerker DJ; Ensinck J; Davidson MB; Goodner CJ
    J Clin Invest; 1975 Apr; 55(4):754-62. PubMed ID: 804491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
    Villaume C; Beck B; Kolopp M; Toussain P; Debry G
    Biomed Pharmacother; 1986; 40(2):61-4. PubMed ID: 2875745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of somatostatin analogs on glucose homeostasis in rats.
    Schmid HA; Brueggen J
    J Endocrinol; 2012 Jan; 212(1):49-60. PubMed ID: 21987782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged suppression of insulin release by a somatostatin analog.
    Lien EL; Garsky VM
    Endocrinology; 1978 Jul; 103(1):81-5. PubMed ID: 744088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of insulin, glucagon, and somatostatin on the release of somatostatin-25 and somatostatin-14 from rainbow trout, Oncorhynchus mykiss, pancreatic islets in vitro.
    Eilertson CD; Kittilson JD; Sheridan MA
    Gen Comp Endocrinol; 1995 Aug; 99(2):211-20. PubMed ID: 8536932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple subcutaneous injections of somatostatin induce tachyphylaxis of the suppression of plasma insulin, but not glucagon, in the rat.
    Märki F; Bucher UM; Richter JC
    Regul Pept; 1982 Nov; 4(6):333-9. PubMed ID: 6129682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive adaptation of the endocrine pancreas during long-term protein deficiency in rats: effects on blood glucose homeostasis and on pancreatic insulin, glucagon and somatostatin concentrations.
    Dollet JM; Beck B; Villaume C; Max JP; Debry G
    J Nutr; 1985 Dec; 115(12):1581-8. PubMed ID: 2866238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of chronic hyperinsulinemia to suppress pancreatic glucagon in vivo in the rat.
    Brubaker PL; Kazumi T; Hirano T; Vranic M; Steiner G
    Can J Physiol Pharmacol; 1991 Mar; 69(3):437-43. PubMed ID: 1676340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of glucagon replacement on the hyperglycemic and hyperketonemic response to prolonged somatostatin infusion in normal man.
    Sherwin RS; Tamborlane W; Hendler R; Saccá L; DeFronzo RA; Felig P
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1104-7. PubMed ID: 925134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of somatostatin and a glucagon-specific analog on glucose homeostasis during arginine infusion.
    Lien EL
    Metabolism; 1978 Sep; 27(9):1095-100. PubMed ID: 682972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycemia and beta-cell adaptation during prolonged somatostatin infusion with glucagon replacement in man.
    Ward WK; Halter JB; Best JD; Beard JC; Porte D
    Diabetes; 1983 Oct; 32(10):943-7. PubMed ID: 6137430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.
    Lien E; Sarantakis D
    Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective effect of some somatostatin analogs on glucagon as opposed to insulin release in rats in vivo.
    Lins PE; Efendić S; Meyers CA; Coy DH; Schally A; Luft R
    Metabolism; 1980 Aug; 29(8):728-31. PubMed ID: 6105610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.